Vertex Pharmaceuticals, Inc (NASDAQ: VRTX) is -6.86% lower on its value in year-to-date trading and has touched a low of $377.85 and a high of $519.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VRTX stock was last observed hovering at around $443.40 in the last trading session, with the day’s loss setting it -441.7%.
Currently trading at $1.70M, the stock is -1.34% and -3.28% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.62 million and changing 3615468% at the moment leaves the stock -4.92% off its SMA200. VRTX registered 9.59% gain for a year compared to 6-month gain of 8.89%. The firm has a 50-day simple moving average (SMA 50) of $456.2806 and a 200-day simple moving average (SMA200) of $464.12646.
The stock witnessed a -0.85% loss in the last 1 month and extending the period to 3 months gives it a -12.19%, and is 0.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.62% over the week and 2.02% over the month.
Vertex Pharmaceuticals, Inc (VRTX) has around 6100 employees, a market worth around $113.32B and $11.04B in sales. Fwd P/E is 21.22. Profit margin for the company is -8.95%. Distance from 52-week low is 16.79% and -15.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-5.45%).
The EPS is expected to grow by 4183.03% this year.
Vertex Pharmaceuticals, Inc (VRTX) Top Institutional Holders
2286.0 institutions hold shares in Vertex Pharmaceuticals, Inc (VRTX), with institutional investors hold 97.94% of the company’s shares. The shares outstanding are 256.97M, and float is at 255.99M with Short Float at 1.58%. Institutions hold 97.78% of the Float.
The top institutional shareholder in the company is CAPITAL WORLD INVESTORS with over 26.71 million shares valued at $12.52 billion. The investor’s holdings represent 10.3479% of the VRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 22.98 million shares valued at $10.77 billion to account for 8.9018 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.31 million shares representing 8.2574% and valued at over $9.99 billion, while STATE STREET CORP holds 4.5432 of the shares totaling 11.73 million with a market value of $5.5 billion.
Vertex Pharmaceuticals, Inc (VRTX) Insider Activity
Still, SEC filings show that on May 15 ’25, ALTSHULER DAVID (EVP, Chief Scientific Officer) disposed off 52 shares at an average price of $424.69 for $22084.0. The insider now directly holds 23,281 shares of Vertex Pharmaceuticals, Inc (VRTX).
